Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Status:
Completed
Trial end date:
2007-04-18
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of different regimens of combination
chemotherapy in treating patients with newly diagnosed mantle cell lymphoma.